|
1
|
Chanan-Khan AA and Cheson BD: Lenalidomide
for the treatment of B-cell malignancies. J Clin Oncol.
26:1544–1552. 2008.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Gurnari C and Maciejewski JP: How I manage
acquired pure red cell aplasia in adults. Blood. 137:2001–2009.
2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ito T, Nakaya A, Fujita S, Satake A,
Nakanishi T, Azuma Y, Tsubokura Y, Konishi A, Hotta M, Yoshimura H,
et al: Secondary pure red cell aplasia in multiple myeloma treated
with lenalidomide. Leuk Res Rep. 10:4–6. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Dolai TK, Dutta S, Mandal PK, Saha S and
Bhattacharyya M: Lenalidomide-induced pure red cell aplasia. Turk J
Haematol. 31:99–100. 2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Hu Q, Liu Y, Yue Q, Zhou S, Jin X, Lin F,
Huang XJ, Zhuang J, Lu J, Gao X and Lee HY: Lenalidomide-induced
pure red cell aplasia is associated with elevated expression of
MHC-I molecules on erythrocytes. Nat Commun.
15(10131)2024.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Li J and Zhou DB: New advances in the
diagnosis and treatment of POEMS syndrome. Br J Haematol.
161:303–315. 2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Dispenzieri A: POEMS syndrome: Update on
diagnosis, risk-stratification, and management. Am J Hematol.
98:1934–1950. 2023.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Nishi J, Arimura K, Utsunomiya A, Yonezawa
S, Kawakami K, Maeno N, Ijichi O, Ikarimoto N, Nakata M, Kitajima
I, et al: Expression of vascular endothelial growth factor in sera
and lymph nodes of the plasma cell type of Castleman's disease. Br
J Haematol. 104:482–485. 1999.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Mineta M, Hatori M, Sano H, Hosaka M,
Kokubun S, Hiroki E, Hatakeyama A and Ogasawara T: Recurrent
Crow-Fukase syndrome associated with increased serum levels of
vascular endothelial growth factor: A case report and review of the
literature. Tohoku J Exp Med. 210:269–277. 2006.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Kanai K, Kuwabara S, Misawa S and Hattori
T: Failure of treatment with anti-VEGF monoclonal antibody for
long-standing POEMS syndrome. Intern Med. 46:311–313.
2007.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Sekiguchi Y, Misawa S, Shibuya K, Nasu S,
Mitsuma S, Iwai Y, Beppu M, Sawai S, Ito S, Hirano S, et al:
Ambiguous effects of anti-VEGF monoclonal antibody (bevacizumab)
for POEMS syndrome. J Neurol Neurosurg Psychiatry. 84:1346–1348.
2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Soubrier M, Dubost JJ, Serre AF, Ristori
JM, Sauvezie B, Cathebras P, Piette JC, Chapman A, Authier FJ and
Gherardi RK: Growth factors in POEMS syndrome: Evidence for a
marked increase in circulating vascular endothelial growth factor.
Arthritis Rheum. 40:786–787. 1997.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Kanai K, Sawai S, Sogawa K, Mori M, Misawa
S, Shibuya K, Isose S, Fujimaki Y, Noto Y, Sekiguchi Y, et al:
Markedly upregulated serum interleukin-12 as a novel biomarker in
POEMS syndrome. Neurology. 79:575–582. 2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Korde N, Zhang Y, Loeliger K, Poon A,
Simakova O, Zingone A, Costello R, Childs R, Noel P, Silver S, et
al: Monoclonal gammopathy-associated pure red cell aplasia. Br J
Haematol. 173:876–883. 2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Verma R: Molecular pathways engaged by
immunomodulatory agents in monoclonal gammopathy-associated pure
red cell aplasia rescue. Front Oncol. 10(1490)2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Li J, Huang XF, Cai QQ, Wang C, Cai H,
Zhao H, Zhang L, Cao XX, Gale RP and Zhou DB: A prospective phase
II study of low dose lenalidomide plus dexamethasone in patients
with newly diagnosed polyneuropathy, organomegaly, endocrinopathy,
monoclonal gammopathy, and skin changes (POEMS) syndrome. Am J
Hematol. 93:803–809. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Franks ME, Macpherson GR and Figg WD:
Thalidomide. Lancet. 363:1802–1811. 2004.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Lacy MQ and McCurdy AR: Pomalidomide.
Blood. 122:2305–2309. 2013.PubMed/NCBI View Article : Google Scholar
|
